1[1] Greene KE,Peters JI.Pathophysilogy of acute respiratory failure[J].Clin Chest Med,1994,15(1):1.
2[2] Donnelly SC,Strieter RM,Reid PT.The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with the adult respiratory distress syndrome[J].Ann Intern Med,1996,125(3):191-196．
3[3] Donnelly SC,MacGregor I,Zamani A.Plasma elastase levels and the development of the adult respiratory distress syndrome[J].Am J Respir Crit Care Med,1995,151(5):1428-1433．
4[4] Demetriades D,Smith JS,Jacobson LE.Bactericideal/permeability-increasing protein(rBPI21) in patients with hemorrhage due to trauma:results of a multicenter phase Ⅱ clinical trial.rBPI21 Acute Hemorrhagic Trauma Study Group[J].J Trauma,1999,46(4):667-676．
5[5] Chesnutt AN,Matthay MA,Tibayan FA.Early detection of type Ⅲ procollagen peptide in acute lung injury.Pathogenetic and prognostic significance[J].Am J Respir Crit Care Med,1997,156(3 Pt 1):840-845．
6[6] Adamson A,Perkins S,Brambilla E.Proliferation,C-myc,and cyclin D1 expression in diffuse alveolar damage:potential roles in pathogenesis and implications for prognosis[J].Hum Pathol,1999,30(9):1050-1057．
7[7] Doyle IR,Bersten AD,Nicholas TE,Surfactant proteins-A and -B are elevated in plasma of patients with acute respiratory failure[J].Am J Respir Crit Care Med,1997,156(4 Pt 1):1217-1296．
8[8] Strayer DS,Herting E,Sun B.Antibody to surfactant protein A increases sensitivity of pulmonary surfactant to inactivation by fibrinogen in vivo[J].Am J Respir Crit Care Med,1996,153(3):1116-1122．
9[9] Goldner MM,Shapiro RS.Acute respiratory failure:update on management[J]．J Respir Dis,1998,19(12);1058.
10[10] Bando M,Lshii Y,Sugiyama Y.Elevated plasma brain natriuretic peptide levels in chronic respiratory failure with cor pulmonale[J]．Respir Med,1999,93(7):507-514．
